NCT02242435View on ClinicalTrials.gov

A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Osteoarthritis of the Knee
Interventions
BIOLOGICAL

4 mL injection of Ampion

4 mL injection of Ampion

DRUG

4 mL Injection of Placebo

Trial Locations (1)

80112

Ampio Pharmaceuticals, Inc., Englewood

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT02242435 - A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis | Biotech Hunter | Biotech Hunter